TrialThe journal of headache and pain2026

Efficacy and safety of transcutaneous supraorbital nerve stimulation versus topiramate for migraine prevention: a non-inferiority randomized trial.

Yuchen Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.